Fifteen isolates of Klebsiella pneumoniae producing extended-spectrum ␤-lactamases (ESBLs) isolated during a nosocomial outbreak were studied. The strains belonged to the same clonal type, as shown by pulsed-field gel electrophoretic analysis of chromosomal DNA. All the isolates were resistant to extended-spectrum cephalosporins, aztreonam, gentamicin, and fluoroquinolones and were susceptible to carbapenems, tobramycin, netilmicin, and amikacin. None of the isolates expressed the OmpK36 porin. Eight isolates, for which the MICs of cefoxitin were >64 g/ml, showed a diminished level or no expression of a 35-kDa porin. The MICs of meropenem, cefotaxime, and cefpirome were three to eight times higher for porin-deficient isolates than for isolates expressing the 35-kDa porin, but the MICs of imipenem increased two times for porin-deficient isolates compared to those for isolates expressing the porin. This MIC increase reverted to a level similar to that for the parental strain when porin-deficient isolates were transformed with the gene coding for the K. pneumoniae porin OmpK36. It is concluded that the high level of resistance to cefoxitin and the increase in the MICs of meropenem, cefotaxime, and cefpirome for the ESBL-producing K. pneumoniae isolates studied are associated with porin deficiency.
␤-lactamase extracts was done with the PhastSystem apparatus (Pharmacia, Uppsala, Sweden) in polyacrylamide gels with a pH range of 3 to 9 (PhastGel 3-9; Pharmacia). The gels were stained with 500 g nitrocefin (Oxoid, Hampshire, England) per ml, and pIs were determined by comparison with different ␤-lactamases with known pIs.
Typing methods. Biotyping was carried out with API 20E galleries (bioMérieux, Balmes les Grottes, France) according to the manufacturer's instructions and with MicroScan NegCombo 6I panels (DADE International, Inc., West Sacramento, Calif.).
Macrorestriction analysis of chromosomal DNA was done by pulsed-field gel electrophoresis (PFGE) by previously described procedures (8) . DNA restriction was done with XbaI (New England Biolabs, Madrid, Spain) following the manufacturer's recommendations. PFGE was performed in a CHEF-DR III apparatus (Bio-Rad, Hercules, Calif.) for 23 h at 14°C with pulse times ranging from 1 to 30 s at 6 V/cm.
OMP isolation and analysis. For porin isolation, we used a combination of the two methods for the isolation of E. coli porins (20, 22) . Cell envelopes were treated with trypsin and subjected to differential solubilization as described in detail by Alberti et al. (1) . The isolated porins were separated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE) and were electrophoretically transferred to Immobilon P membranes (Millipore, Barcelona, Spain) by using the buffers and conditions described by Towbin et al. (29) . The membranes were stained with Ponceau red, and bands of interest were excised separately, destained, and sequenced in an Applied Biosystems 470 gas-phase sequencer (kindly done by the Servicio de Secuenciación of the Centro de Investigaciones Biológicas del Consejo Superior de Investigaciones Cientificas, Madrid, Spain).
K. pneumoniae strains were grown in Mueller-Hinton broth and sonicated, and cell envelopes were recovered by ultracentrifugation. After treatment with sodium N-lauroyl sarcosinate (Sigma, Madrid, Spain), the OMPs were collected by ultracentrifugation (15) . Electrophoretic analysis of OMP by SDS-PAGE was performed in 11% acrylamide-0.35% bisacrylamide-0.1% SDS by using Laemmli's buffers. The samples were boiled for 5 min in Laemmli's buffer before electrophoresis. The gels were stained with Coomassie blue.
Transfer and expression of ompK36 gene. Plasmid pSUV7, containing the gene coding for the OmpK36 porin, and plasmid pFR167, containing a truncated ompK36 gene, have been described previously (15) . These plasmids include a kanamycin resistance cassette to allow their selection in the multidrug-resistant background of strain CSUB10R. Briefly, the kanamycin resistance cassette of plasmid pCSI2 (6) was obtained as an XbaI-XbaI fragment and was cloned into the unique XbaI sites of plasmids pSUV7 and pFR167. The result was plasmid pSHA19, which contains the ompK36 gene, and plasmid pSHA20, which contains a truncated ompK36 gene. The modified plasmids were introduced by electroporation into strain CSUB10R, and the transformed CSUB10R strains carrying the cloned porin genes were selected as kanamycin-resistant strains. DNA isolation, enzyme restrictions, and ligation were performed by standard procedures (28) .
RESULTS

Susceptibility testing.
All the strains tested were resistant to amoxicillin (MIC, Ͼ256 g/ml) and piperacillin (MICs, 128 to Ͼ256 g/ml). The amoxicillin-clavulanic acid MICs ranged from 4 to 16 g/ml, whereas the piperacillin-tazobactam MIC range was from 2 to Ͼ256 g/ml. For cefoxitin-resistant strains, the addition of clavulanic acid did not result in a reversion to cefoxitin susceptibility. Amikacin (MIC, 2 g/ml), tobramycin (MIC range, 0.5 to 1 g/ml), and netilmicin (MIC range, 0.5 to 2 g/ml) were active against all K. pneumoniae isolates. All the isolates were resistant to gentamicin (MIC range, 8 to 16 g/ml). Table 1 presents the MICs of 11 antibiotics for cefoxitinsusceptible and -resistant isolates cultured from the same patient and the MICs of these antibiotics for CSUB10R (pSHA19) and CSUB10R(pSHA20) containing the entire and truncated ompK36 porin genes, respectively. For cefoxitin-resistant isolates, the MICs of cefotaxime (3 to 5 dilution steps), cefpirome (5 to 7 dilution steps), meropenem (5 to 6 dilution steps), imipenem (2 dilution steps), and ceftazidime-clavulanic acid (2 dilution steps) were higher than those for the cefoxitinsusceptible strains. The quinolone MICs for cefoxitin-resistant strains were always from 1 to 3 dilution steps higher than those for cefoxitin-susceptible strains. For strain CSUB10R, the cefoxitin resistance and the increased MICs of meropenem, cefotaxime, cefpirome, and ceftazidime-clavulanic acid reverted to MICs which were similar to those for strain CSUB10S after cloning of the ompK36 gene into the strain [strain CSUB10R(pSHA19)]. Table 2 presents the MICs of 11 antibiotics for K. pneumoniae isolates with different degrees of resistance to cefoxitin. For isolates for which the cefoxitin MIC was Ն64 g/ml, the cefpirome and cefotaxime MICs increased and the meropenem MIC was 4 to 32 times higher than those for strains for which cefoxitin MICs were Ͻ64 g/ml. The MICs of norfloxacin (MIC range, 64 to 128 g/ml), ofloxacin (MIC range, 4 to 8 g/ml), ciprofloxacin (MIC range, 2 to 8 g/ml), or sparfloxacin (MIC range, 1 to 4 g/ml) cannot be related to the degree of cefoxitin resistance.
E. coli transconjugants, with K. pneumoniae CSUB10R or CSUB10S used as donors, were resistant to expanded-spectrum cephalosporins as a result of ESBL production. Cefoxitin resistance and increased carbapenem MICs were not transferred to E. coli by conjugation of the donor.
␤-Lactamase study. The production of ESBLs was demonstrated in all the strains by the double-disk synergy test and by at least a threefold reduction in the ceftazidime MIC when clavulanic acid was added. Isoelectric focusing of ␤-lactamase extracts showed that all but one of the isolates produced a to Ͼ256 g/ml) was higher than that for those producing a ␤-lactamase with a pI of 7.6 (MIC range, 0.5 to 32 g/ml). Typing methods. All 15 isolates exhibited the same biotype by testing both with the API 20E and the MicroScan systems. A major PFGE pattern after chromosomal DNA restriction with XbaI was found (Fig. 1) . This pattern showed only five minor variations (subtypes A1 to A5), and overall, the isolates were considered to be clonally related to the dominant strain found during the outbreak. There was no relationship between the PFGE subtypes of the strains and porin expression. Pairs of cefoxitin-resistant and cefoxitin-susceptible isolates from three patients also had identical PFGE patterns.
OMP analysis. SDS-PAGE analysis of the OMPs showed that all the clinical isolates expressed two OMPs of about 32 and 45 kDa and that isolates for which cefoxitin MICs were Ͻ128 g/ml also expressed an additional OMP of about 35 kDa ( Fig. 2 and 3) . The 32-kDa protein is probably the K. pneumoniae homolog of E. coli OmpA because of its increased mobility (molecular mass, about 22 kDa) in samples solubilized at 37°C (data not shown). The 45-kDa band was isolated from strain CSUB10R (Fig. 4) by a porin isolation method, and N-terminal analysis of its first 12 amino acids showed that it had complete identity with K. pneumoniae LamB. The porin isolation method, when applied to strain CSUB10S, produced the 35-and 45-kDa proteins (Fig. 4) . After SDS-PAGE separation, they were transferred to a polyvinylidene difluoride membrane, and their N termini were sequenced. Sequence analysis confirmed that 45-kDa protein corresponds to LamB, while the 35-kDa sequence demonstrated that it is a nonspecific pore protein (porin). The complete identity of the first amino acids of the OmpK36 and OmpK35 porins from K. pneumoniae and other enterobacterial porins (13) prevented assignment of the 35-kDa porin to either one of the two porins of the species. This 35-kDa porin was absent from isolates for which the cefoxitin MIC was 128 g/ml (Fig. 2 and 3) . Expression of this porin, as judged by SDS-PAGE, was reduced in isolates for which cefoxitin MICs were 64 g/ml, while sufficient expression of this porin was found in isolates for which cefoxitin MICs were 32 g/ml ( Fig. 2 and 3) .
DISCUSSION
Nosocomial outbreaks due to ESBL-producing enterobacteria have become a serious problem worldwide (12, 17, 18) . Treatment of infections due to these microorganisms is a difficult task because ␤-lactamase production inactivates most of the ␤-lactam antibiotics, and these microorganisms are usually resistant to other antibiotic groups such as aminoglycosides and quinolones. Cephamycins such as cefoxitin are active in vitro against these strains, but this agent can select porin-deficient mutants with increased levels of resistance to cefoxitin and other cephalosporins (15, 23, 30) . Combinations of a ␤-lactam and a ␤-lactamase inhibitor are not always active against these microorganisms (27) . Carbapenems also remain a good option, but the emergence of imipenem-resistant strains of Pseudomonas aeruginosa and other gram-negative bacilli could occur when imipenem is widely used (17) . In addition, it has recently been described that K. pneumoniae becomes carbapenem resistant as a result of porin deficiency and plasmidmediated AmpC-like ␤-lactamases (2, 16). The loss of porins OmpC and OmpF as a cause of antibiotic resistance has been noted in several reports, especially for E. coli and Salmonella typhimurium (21) . In K. pneumoniae, loss of both the OmpK35 and the OmpK36 porins has been shown to cause increased levels of resistance to cefoxitin and extended-spectrum cephalosporins and probably contributes to ciprofloxacin resistance (4, 15, 30) . This resistance phenotype reverted when the strain expressed OmpK36 porin in its outer membrane after cloning of the ompK36 gene (15) .
During an outbreak caused by K. pneumoniae producing ESBLs in our hospital (25) , 4% of the isolates were highly resistant to cefoxitin (MICs, Ն128 g/ml). Porin deficiency was associated with this resistance phenotype, and the diminished level of expression of this protein was related to a cefoxitin MIC of 64 g/ml. In addition, porin deficiency was associated with increased MICs of cefotaxime and cefpirome, probably because in porin-deficient mutants the uptake of extendedspectrum cephalosporins is less effective than that in porinsufficient strains (23) . Thus, the combination of the decreased outer membrane permeation and the hydrolytic effect of ESBLs increased the MICs of expanded-spectrum cephalosporins for the resistant strains studied.
The six porin-deficient strains showed 8-to 32-fold decreased susceptibilities to meropenem but only 2-fold decreased susceptibilities to imipenem. The MICs of meropenem were four times higher than those of imipenem. When isolate CSUB10R was transformed with a gene coding for the OmpK36 K. pneumoniae porin, this resistance phenotype reverted and the MICs of carbapenems for this strain were similar to those for the CSUB10S strain that expresses the OmpK36 porin and that was isolated from the same clinical sample as strain CSUB10R. These findings suggest a main role of this porin in the decreased susceptibility of K. pneumoniae to meropenem. The association between the loss of porins and imipenem resistance has recently been described in K. pneumoniae producing plasmid-mediated AmpC-like ␤-lactamase (2, 16) . In other members of the family Enterobacteriaceae such as Enterobacter cloacae and Proteus rettgerii, resistance to carbapenems has been related to diminished outer membrane permeability and hydrolysis by the overproduced chromosomal ␤-lactamase (5, 26) . It seems that, like in E. cloacae, the level of meropenem susceptibility in K. pneumoniae is more dependent on porin expression, whereas imipenem susceptibility is less affected by this resistance mechanism and is more dependent on the production of secondary ␤-lactamases of the AmpC type (2, 5, 16, 26) . It is difficult to determine the exact mechanism by which the loss of porins results in decreased meropenem susceptibility. In independent studies, we have shown that strain CSUB10R produces an active efflux mechanism causing decreased levels of accumulation of fluoroquinolones in the cell (unpublished observation). A similar mechanism has been observed in P. aeruginosa with reduced susceptibility to meropenem when the efflux system MexAB-OprM is expressed. Experiments are in progress to determine a possible link between the efflux of meropenem and decreased susceptibility to this carbapenem.
In a comparison of the three pairs of cefoxitin-susceptible and -resistant strains isolated from the same patient, from twoto eightfold increases in the quinolone MICs were found. In addition, for strain CSUB10R from patient 1, a two-to fourfold decrease in the quinolone MICs was observed after the OmpK36 porin was introduced into this strain. This relationship has been reported previously (9, 15, 30) , suggesting that loss of porin can contribute to quinolone resistance. However, this cross-resistance did not correlate with the degree of cefoxitin resistance in the other K. pneumoniae isolates studied. The relative importance of the possible mechanisms involved in quinolone resistance are under investigation; however, mutations have been detected in the quinolone resistance-determining region of gyrA but not that of parC in both CSUB10R and CSUB10S strains (unpublished observations); in addition, an active efflux mechanism causing a decreased level of accumulation of fluoroquinolones was detected in strain CSUB10R. 3) and CSUB10R (lanes 2 and 4) . Lanes 1 and 2, OMP; lanes 3 and 4, porins. Numbers on the left side correspond to the approximate molecular masses of the proteins (in kilodaltons).
By PFGE there was a clonal relationship among the highly cefoxitin-resistant K. pneumoniae isolates; moreover, these isolates belonged to the same clone as the epidemic strain (which was cefoxitin susceptible) responsible for the outbreak. This suggests the in vivo selection of porin-deficient mutants from a common ancestor, i.e., the epidemic strain, as reported previously (15, 23) . 
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